Replies

Reply to Kaiser solicitation to get the 'jab' -

Victims 'jabbed' with the experimental genetic therapy are more likely to be affected by the Delta variant than survivors of CoVID (or SARS) who have natural immunity. 'Jabbed' victims are more likely to be spreaders of the Delta variant than the naturally immune.
'The CDC 'experts' said the spikes from the 'jab' would be localized, but autopsies show them in all organs of CoVID victims, including the brain. So CDC advises healthcare providers not to perform autopsies for deaths 'obviously' from CoVID.
The 'jab' is being found to be ineffective, unlike long term natural immunity, and requires further 'jabs' for 'protection' that outweighs the risks for most people Spike damage from clotting microscopic blood vessels will slowly increase blood pressure and related diseases over time, significantly increasing health costs for all. Good for Kaiser profits and Big Pharma, not so good for population.
Kaiser does not do autopsies of CoVID victims in order to hide the truth from the public about natural immunity.
There is no scientific basis for wearing porous masks against a virus, either statistically or from medical literature. The psychological harm of forcing kids to wear masks is reprehensible and is an obvious political act of war against our population.
Kaiser is forcing their medical practitioners to be 'jabbed' without regard to their natural immunity in an obvious display of politics overpowering established science, and is an obvious political act of war against our population.
Your 'no cost COVID-19 test' does not address long term natural immunity like a t-cell assay does, and does not distinguish between seasonal flu and CoVID.
For the reasons above I choose to remain in the CONTROL GROUP of this medical-political experiment of population control and rely on the natural immunity God gave us from his Infinite Wisdom. You can keep your genetic experiments among yourselves, and good luck with that.

https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1.full

Results The cohort included 33,993 fully vaccinated adults, 49% women, with a mean age of 47 years (SD, 17 years), who received an RT-PCR test for SARS-CoV-2 during the study period. The median time between the second dose of the vaccine and the RT-PCR test was 146 days, interquartile range [121-167] days. 608 (1.8%) patients had positive test results. There was a significantly higher rate of positive results among patients who received their second vaccine dose at least 146 days before the RT-PCR test compared to patients who have received their vaccine less than 146 days before: odds ratio for infection was 3.00 for patients aged over 60 (95% CI 1.86-5.11); 2.29 for patients aged between 40 and 59 (95% CI 1.67-3.17); and 1.74 for patients aged between 18 and 39 (95% CI 1.27-2.37); P<0.001 in each age group.

Conclusions and Relevance In this large population study of patients tested for SARS-CoV-2 by RT-PCR following two doses of mRNA BNT162b2 vaccine, we observe a significant increase of the risk of infection in individuals who received their last vaccine dose since at least 146 days ago, particularly among patients older than 60.